Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Am J Physiol Endocrinol Metab ; 326(5): E681-E695, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38597829

ABSTRACT

Hypothalamic proopiomelanocortin (POMC) neurons are sensors of signals that reflect the energy stored in the body. Inducing mild stress in proopiomelanocortin neurons protects them from the damage promoted by the consumption of a high-fat diet, mitigating the development of obesity; however, the cellular mechanisms behind these effects are unknown. Here, we induced mild stress in a proopiomelanocortin neuron cell line by inhibiting Crif1. In proopiomelanocortin neurons exposed to high levels of palmitate, the partial inhibition of Crif1 reverted the defects in mitochondrial respiration and ATP production; this was accompanied by improved mitochondrial fusion/fission cycling. Furthermore, the partial inhibition of Crif1 resulted in increased reactive oxygen species production, increased fatty acid oxidation, and reduced dependency on glucose for mitochondrial respiration. These changes were dependent on the activity of CPT-1. Thus, we identified a CPT-1-dependent metabolic shift toward greater utilization of fatty acids as substrates for respiration as the mechanism behind the protective effect of mild stress against palmitate-induced damage of proopiomelanocortin neurons.NEW & NOTEWORTHY Saturated fats can damage hypothalamic neurons resulting in positive energy balance, and this is mitigated by mild cellular stress; however, the mechanisms behind this protective effect are unknown. Using a proopiomelanocortin cell line, we show that under exposure to a high concentration of palmitate, the partial inhibition of the mitochondrial protein Crif1 results in protection due to a metabolic shift warranted by the increased expression and activity of the mitochondrial fatty acid transporter CPT-1.


Subject(s)
Carnitine O-Palmitoyltransferase , Cell Cycle Proteins , Fatty Acids , Mitochondria , Animals , Mice , Carnitine O-Palmitoyltransferase/metabolism , Carnitine O-Palmitoyltransferase/genetics , Cell Line , Fatty Acids/metabolism , Hypothalamus/metabolism , Hypothalamus/drug effects , Mitochondria/metabolism , Mitochondria/drug effects , Neurons/drug effects , Neurons/metabolism , Pro-Opiomelanocortin/metabolism , Pro-Opiomelanocortin/genetics , Reactive Oxygen Species/metabolism , Cell Cycle Proteins/antagonists & inhibitors , Cell Cycle Proteins/metabolism
2.
EMBO Rep ; 21(9): e49828, 2020 09 03.
Article in English | MEDLINE | ID: mdl-32672883

ABSTRACT

While brown adipose tissue (BAT) is well-recognized for its ability to dissipate energy in the form of heat, recent studies suggest multifaced roles of BAT in the regulation of glucose and lipid homeostasis beyond stimulating thermogenesis. One of the functions involves interorgan communication with metabolic organs, such as the liver, through BAT-derived secretory factors, a.k.a., batokine. However, the identity and the roles of such mediators remain insufficiently understood. Here, we employed proteomics and transcriptomics in human thermogenic adipocytes and identified previously unappreciated batokines, including phospholipid transfer protein (PLTP). We found that increased circulating levels of PLTP, via systemic or BAT-specific overexpression, significantly improve glucose tolerance and insulin sensitivity, increased energy expenditure, and decrease the circulating levels of cholesterol, phospholipids, and sphingolipids. Such changes were accompanied by increased bile acids in the circulation, which in turn enhances glucose uptake and thermogenesis in BAT. Our data suggest that PLTP is a batokine that contributes to the regulation of systemic glucose and lipid homeostasis as a mediator of BAT-liver interorgan communication.


Subject(s)
Adipose Tissue, Brown , Glucose , Adipose Tissue, Brown/metabolism , Energy Metabolism , Glucose/metabolism , Homeostasis , Humans , Lipids , Liver , Thermogenesis
3.
J Physiol ; 597(16): 4277-4291, 2019 08.
Article in English | MEDLINE | ID: mdl-31228206

ABSTRACT

KEY POINTS: We report that the peroxisome proliferator-activated receptor (PPAR)γ coactivator 1-α (PGC-1α)/PPARß axis is a crucial mediator of uncoupling protein 3 (UCP3) expression in skeletal muscle cells via the transactivativation of a distal PPAR response element at the Ucp3 gene promoter. This mechanism is activated during the myogenic process and by high concentrations of fatty acids independent of PGC-1α protein levels. Ucp3 is essential for PGC-1α-induced oxidative capacity and the adaptive mitochondrial response to fatty acid exposure. These findings provide further evidence for the broad spectrum of the coactivator action in mitochondrial homeostasis, positioning the PGC-1ɑ/PPARß axis as an essential component of the molecular regulation of Ucp3 gene in skeletal muscle cells. ABSTRACT: Uncoupling protein 3 (UCP3) has an essential role in fatty acid metabolism and mitochondrial redox regulation in skeletal muscle. However, the molecular mechanisms involved in the expression of Ucp3 are poorly known. In the present study, we show that the peroxisome proliferator-activated receptor (PPAR)γ coactivator 1-α (PGC-1α)/PPARß axis is a crucial mediator of Ucp3 expression in skeletal muscle cells. In silico analysis of the UCP3 promoter and quantitative chromatin immunoprecipitation experiments revealed that the induction of the UCP3 transcript is mediated by the transactivation of a distal PPAR response element at the Ucp3 gene promoter by the coactivator PGC-1α. This mechanism is activated during myogenesis and during metabolic stress induced by fatty acids independent of PGC-1α protein levels. We also provide evidence that Ucp3 is essential for PGC-1α-induced oxidative capacity. Taken together, our results highlight PGC-1ɑ/PPARß as an essential component of the molecular regulation of Ucp3 gene in skeletal muscle cells.


Subject(s)
Computer Simulation , Gene Expression Regulation/physiology , Uncoupling Protein 3/metabolism , Animals , Base Sequence , Cell Line , Computational Biology , Humans , Mice , Muscle Development , Myoblasts/physiology , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Promoter Regions, Genetic , Protein Binding , Uncoupling Protein 3/genetics
4.
J Cell Physiol ; 232(5): 958-966, 2017 05.
Article in English | MEDLINE | ID: mdl-27736004

ABSTRACT

Mitochondria play a critical role in several cellular processes and cellular homeostasis. Mitochondrion dysfunction has been correlated with numerous metabolic diseases such as obesity and type 2 diabetes. MicroRNAs are non-coding RNAs that have emerged as key regulators of cell metabolism. The microRNAs act as central regulators of metabolic gene networks by leading to the degradation of their target messenger RNA or repression of protein translation. In addition, vesicular and non-vesicular circulating miRNAs exhibit a potential role as mediators of the cross-talk between the skeletal muscle and other tissues/organs. In this review, we will focus on the emerging knowledge of miRNAs controlling mitochondrial function and insulin signaling in skeletal muscle cells. J. Cell. Physiol. 232: 958-966, 2017. © 2016 Wiley Periodicals, Inc.


Subject(s)
Insulin/metabolism , MicroRNAs/metabolism , Mitochondria/metabolism , Muscle, Skeletal/metabolism , Organelle Biogenesis , Signal Transduction , Humans
5.
Am J Physiol Heart Circ Physiol ; 306(12): H1679-91, 2014 Jun 15.
Article in English | MEDLINE | ID: mdl-24748593

ABSTRACT

The number of studies that have evaluated exercise training (ET) and nitric oxide synthase (NOS)3 gene polymorphisms is scarce. The present study was designed to evaluate the relationship between exercise training and NOS3 polymorphisms at -786T>C, 894G>T, and intron 4b/a on blood pressure (BP) using 24-h ambulatory BP monitoring (ABPM), nitrate/nitrite levels (NOx), and redox state. Eighty-six volunteers (51 ± 0.6 yr old) were genotyped into nonpolymorphic and polymorphic groups for each of the three positions of NOS3 polymorphisms. Auscultatory BP, ABPM, SOD activity, catalase activity, NOx levels, and malondialdehyde levels were measured. DNA was extracted from leukocytes, and PCR followed by sequencing was applied for genotype analysis. Aerobic ET consisted of 24 sessions for 3 days/wk for 40 min at moderate intensity. This study was performed in a double-blind and crossover format. ET was effective in lowering office BP (systolic BP: 3.2% and diastolic BP: 3%) as well as ABPM (systolic BP: 2% and diastolic BP: 1.3%). Increased SOD and catalase activity (42.6% and 15.1%, respectively) were also observed. The NOS3 polymorphism for intron 4 mitigated the beneficial effect of ET for systolic BP (nonpolymorphic group: -3.0% and polymorphic group: -0.6%) and diastolic BP (nonpolymorphic group: -3.2% and polymorphic group: -0.5%), but it was not associated with NOx level and redox state. Paradoxical responses were found for positions T786-C and G894T for the NOS3 gene. Consistently, the presence of the polymorphism for intron 4 blunted the beneficial effects of ET in middle-aged adults. Possibly, this effect might be as consequence of intron 4 acting as a short intronic repeat RNA controlling endothelial NOS activity epigenetically.


Subject(s)
Blood Pressure Monitoring, Ambulatory , Blood Pressure/physiology , Exercise/physiology , Introns/genetics , Nitric Oxide Synthase Type III/genetics , Polymorphism, Genetic/genetics , Alleles , Catalase/blood , Cross-Over Studies , Double-Blind Method , Female , Genotype , Haplotypes/genetics , Humans , Male , Middle Aged , Superoxide Dismutase/blood
6.
Trends Endocrinol Metab ; 33(8): 587-599, 2022 08.
Article in English | MEDLINE | ID: mdl-35697585

ABSTRACT

Owing to its unique capacity to clear macronutrients from circulation and use them to produce heat, thermogenic fat is capable of regulating glucose, lipids, and branched-chain amino acids (BCAA) circulatory levels. At the same time, its activity yields a higher energy expenditure, thereby conferring protection against cardiometabolic diseases. Our knowledge on the mechanisms of uptake and intracellular metabolism of such energy substrates into thermogenic fat has meaningfully evolved in recent years. This has allowed us to better understand how the thermogenic machinery processes those molecules to utilize them as substrates for heating up the body. Here, we discuss recent advances in the molecular and cellular regulatory process that governs the uptake and metabolism of such substrates within thermogenic fat.


Subject(s)
Adipose Tissue, Brown , Hot Temperature , Adipose Tissue, Brown/metabolism , Energy Metabolism/physiology , Humans , Thermogenesis/genetics , Uncoupling Protein 1/metabolism
7.
Eur J Cardiovasc Prev Rehabil ; 17(6): 676-81, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20436351

ABSTRACT

INTRODUCTION: The aim of this study was to investigate whether -786T>C endothelial nitric oxide synthase (eNOS) gene polymorphism might influence the effect of long-term exercise training (ET) on the blood pressure and its relationship with NO production in healthy postmenopausal women. DESIGN: Longitudinal study. METHOD: Fifty-five postmenopausal women were studied in a double-blinded design. ET was performed for 3 days a week, each session consisting of 60 min during 6 months, in an intensity of 50-70% VO2max. After that, eNOS genotype analysis was performed and women were divided into two groups: TC+CC (n=41) and TT (n=14) genotype. RESULTS: No changes were found in the anthropometric parameters after ET in both the groups. Systolic and diastolic BP values were significantly reduced in both the groups, but women with TT genotype were more responsive in lowering BP as compared with those with TC+CC genotype. Plasma nitrite/nitrate concentrations were similar at baseline in both the groups, but the magnitude of increment in NO production in response to ET was higher in women with TT genotype as compared with those with TC+CC genotype. CONCLUSION: Our study shows clearly that women with or without eNOS gene polymorphism had no differences in NO production at basal conditions, but when physical exercise is applied an evident difference is detected showing that the presence of -786T>C eNOS gene polymorphism had a significant impact in the health-promoting effect of aerobic physical training on the blood pressure in postmenopausal women.


Subject(s)
Blood Pressure , Exercise Therapy , Hypertension/therapy , Nitric Oxide Synthase Type III/genetics , Polymorphism, Genetic , 5' Flanking Region , Double-Blind Method , Female , Genotype , Humans , Hypertension/enzymology , Hypertension/genetics , Hypertension/physiopathology , Longitudinal Studies , Middle Aged , Nitrates/blood , Nitrites/blood , Phenotype , Postmenopause , Time Factors , Treatment Outcome , Women's Health
8.
Free Radic Biol Med ; 143: 203-208, 2019 11 01.
Article in English | MEDLINE | ID: mdl-31408725

ABSTRACT

The ability to respond to fluctuations of reactive oxygen species (ROS) within the cell is a central aspect of mammalian physiology. This dynamic process depends on the coordinated action of transcriptional factors to promote the expression of genes encoding for antioxidant enzymes. Here, we demonstrate that the transcriptional coregulators, PGC-1α and NCoR1, are essential mediators of mitochondrial redox homeostasis in skeletal muscle cells. Our findings reveal an antagonistic role of these coregulators in modulating mitochondrial antioxidant induction through Sod2 transcriptional control. Importantly, the activation of this mechanism by either PGC-1α overexpression or NCoR1 knockdown attenuates mitochondrial ROS levels and prevents cell death caused by lipid overload in skeletal muscle cells. The opposing actions of coactivators and corepressors, therefore, exert a commanding role over cellular antioxidant capacity.


Subject(s)
Gene Expression Regulation , Mitochondria/metabolism , Nuclear Receptor Co-Repressor 1/metabolism , Oxidation-Reduction/drug effects , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/metabolism , Animals , Antioxidants/metabolism , Caenorhabditis elegans , Cell Survival , Green Fluorescent Proteins/metabolism , Homeostasis , Lipids/chemistry , Mice , Muscle, Skeletal/metabolism , Palmitates/pharmacology , Propidium/pharmacology , RNA, Small Interfering/metabolism , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism , Trans-Activators/metabolism , Transcription, Genetic
9.
Sci Rep ; 7: 46750, 2017 04 21.
Article in English | MEDLINE | ID: mdl-28429777

ABSTRACT

Impairment of the insulin-degrading enzyme (IDE) is associated with obesity and type 2 diabetes mellitus (T2DM). Here, we used 4-mo-old male C57BL/6 interleukin-6 (IL-6) knockout mice (KO) to investigate the role of this cytokine on IDE expression and activity. IL-6 KO mice displayed lower insulin clearance in the liver and skeletal muscle, compared with wild type (WT), due to reduced IDE expression and activity. We also observed that after 3-h incubation, IL-6, 50 and 100 ng ml-1, increased the expression of IDE in HEPG2 and C2C12 cells, respectively. In addition, during acute exercise, the inhibition of IL-6 prevented an increase in insulin clearance and IDE expression and activity, mainly in the skeletal muscle. Finally, IL-6 and IDE concentrations were significantly increased in plasma from humans, after an acute exercise, compared to pre-exercise values. Although the increase in plasma IDE activity was only marginal, a positive correlation between IL-6 and IDE activity, and between IL-6 and IDE protein expression, was observed. Our outcomes indicate a novel function of IL-6 on the insulin metabolism expanding the possibilities for new potential therapeutic strategies, focused on insulin degradation, for the treatment and/or prevention of diseases related to hyperinsulinemia, such as obesity and T2DM.


Subject(s)
Gene Expression Regulation, Enzymologic/drug effects , Insulin/metabolism , Insulysin/genetics , Interleukin-6/pharmacology , Animals , Cell Line , Hep G2 Cells , Humans , Insulysin/blood , Insulysin/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Liver/drug effects , Liver/metabolism , Male , Mice, Inbred C57BL , Mice, Knockout , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Physical Conditioning, Animal
10.
Diabetes Res Clin Pract ; 111: 19-27, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26678666

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate: (1) the cardiovascular parameters and plasma biomarkers in people with type 1 diabetes mellitus (T1DM) at baseline; and (2) the heart rate variability (HRV) and blood glucose in response to a session of aerobic exercise (AE) and during recovery period. RESEARCH DESIGN AND METHODS: Adults (18-35 years) were divided into two groups: control (CT, n=10) and T1DM (n=9). Anthropometric, cardiovascular, and biochemical parameters, and aerobic capacity (indirect peak oxygen uptake, VO2peak) were evaluated at baseline. Thirty minutes of AE (40-60% intensity) was performed on a treadmill. Blood glucose and HRV were determined at rest, during AE, and during the recovery period. RESULTS: Anthropometric measurements, cardiovascular parameters, aerobic capacity, and biochemical parameters were similar between the groups at baseline. In the T1DM group, blood glucose, glycated hemoglobin, and thiobarbituric acid reactive substances concentrations were increased while nitrite/nitrate (NOx(-)) levels were reduced. During AE, the magnitude of the reduction of blood glucose was greater than that during the recovery period in the T1DM group. The RR intervals and SDNN were reduced at rest as well as in the recovery period in T1DM subjects, whereas the RMSSD and pNN50 were only reduced during the recovery period. No changes were observed in low frequency (LF), high frequency (HF), and LF/HF ratio. CONCLUSION: Our study shows that T1DM patients on insulin therapy have poor blood glucose control with greater lipid peroxidation and lower NOx(-) levels, accompanied by an imbalance in autonomic function detected by the challenge of AE.


Subject(s)
Biomarkers/blood , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/physiopathology , Exercise/physiology , Heart Rate/physiology , Adolescent , Adult , Blood Glucose/analysis , Exercise Test , Female , Glycated Hemoglobin/analysis , Humans , Insulin/blood , Male , Young Adult
11.
Arq Bras Endocrinol Metabol ; 57(1): 33-43, 2013 Feb.
Article in Portuguese | MEDLINE | ID: mdl-23440097

ABSTRACT

OBJECTIVE: To evaluate the influence of the interaction between endothelial nitric oxide synthase gene (NOS3) polymorphisms at positions -786T>C, Glu298Asp and intron 4b/a, and cardiorespiratory fitness on plasma nitrite/nitrate levels, blood pressure, lipid profile, and prevalence of cardiometabolic disorders. SUBJECTS AND METHODS: Ninety-two volunteers were genotyped for NOS3 polymorphisms at positions (-786T>C and Glu298Asp) and (intron 4b/a) and divided according to the genotype: non-polymorphic (NP) and polymorphic (P). After that, they were subdivided according to the cardiorespiratory fitness associated with genotype: high (HNP and HP) and low (LNP and LP). RESULTS: The subjects with polymorphism for the interactions at positions Glu298Asp + intron 4b/a, and Glu298Asp+-786T>C showed the highest values in total cholesterol, as well as dyslipidemia. CONCLUSION: Our findings show that NOS3 gene polymorphisms at positions -786T>C, Glu298Asp, and intron 4b/a exert negative effects on the lipid profile compared with those who do not carry polymorphisms.


Subject(s)
Dyslipidemias/genetics , Nitric Oxide Synthase Type III/genetics , Polymorphism, Genetic/genetics , Cardiovascular System/physiopathology , Cholesterol/blood , Dyslipidemias/blood , Dyslipidemias/epidemiology , Epidemiologic Methods , Female , Genotype , Glutamic Acid/genetics , Humans , Introns/genetics , Male , Middle Aged , Nitrates/blood , Nitrites/blood , Oxygen Consumption/genetics , Promoter Regions, Genetic/genetics , Respiratory System/physiopathology
12.
Arch Physiol Biochem ; 117(5): 265-9, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21801125

ABSTRACT

CONTEXT: Presence of endothelial nitric oxide synthase (eNOS) gene polymorphism has been associated with cardiovascular disease (CVD) whereas exercise training (EX) promotes beneficial effects on CVD which is related to increased nitric oxide levels (NO). OBJECTIVE: To evaluate if women with eNOS gene polymorphism at position-G894T would be less responsive to EX than those who did not carry T allele. METHODS: Women were trained 3 days/week, 40 minutes session during 6 months. Cardio-biochemical parameters and genetic analysis were performed in a double-blind fashion. RESULTS: Plasma NOx- levels were similar in both groups at baseline (GG genotype: 18.44±3.28 µM) and (GT+TT genotype: 17.19±2.43 µM) and after EX (GG: 29.20±4.33 and GT+TT: 27.38±3.12 µM). A decrease in blood pressure was also observed in both groups. DISCUSSION AND CONCLUSION: The presence of eNOS polymorphism does not affect the beneficial effects of EX in women.


Subject(s)
Cardiovascular Diseases/prevention & control , Exercise , Nitric Oxide Synthase Type III/genetics , Nitric Oxide/blood , Polymorphism, Single Nucleotide , Alleles , Blood Pressure , Brazil , Cardiovascular Diseases/enzymology , Cardiovascular Diseases/genetics , Case-Control Studies , Double-Blind Method , Female , Gene Frequency , Genotype , Humans , Middle Aged , Nitric Oxide/biosynthesis , Nitric Oxide Synthase Type III/blood
13.
Arq. bras. endocrinol. metab ; 57(1): 33-43, fev. 2013. ilus, graf, tab
Article in Portuguese | LILACS | ID: lil-665760

ABSTRACT

OBJETIVO: Analisar a influência da associação dos polimorfismos do gene da sintase do óxido nítrico endotelial (NOS3) para as posições -786T>C, Glu298Asp e íntron 4b/a e a aptidão cardiorrespiratória sobre as concentrações de nitrito/nitrato, pressão arterial, perfil lipídico e prevalência de doenças cardiometabólicas em adultos. SUJEITOS E MÉTODOS: Noventa e duas pessoas foram divididas de acordo com o genótipo: não polimórficas (NP) e polimórficas (P). Posteriormente, foram subdivididas pela aptidão cardiorrespiratória associada ao genótipo: alta (ANP e AP) ou baixa (BNP e BP). RESULTADOS: Os indivíduos que apresentavam polimorfismo para as posições Glu298Asp+Íntron 4b/a e Glu298Asp+-786T>C e baixa aptidão cardiorrespiratória apresentaram maiores valores de colesterol total e maior prevalência de dislipidemia. CONCLUSÃO: Nossos dados demonstram que os polimorfismos do gene da NOS3 para essas duas associações influenciam os níveis de colesterol plasmático, e essa associação foi mais claramente observada quando os indivíduos apresentavam menor nível de aptidão cardiorrespiratória.


OBJECTIVE: To evaluate the influence of the interaction between endothelial nitric oxide synthase gene (NOS3) polymorphisms at positions -786T>C, Glu298Asp and intron 4b/a, and cardiorespiratory fitness on plasma nitrite/nitrate levels, blood pressure, lipid profile, and prevalence of cardiometabolic disorders. SUBJECTS AND METHODS: Ninety-two volunteers were genotyped for NOS3 polymorphisms at positions (-786T>C and Glu298Asp) and (intron 4b/a) and divided according to the genotype: non-polymorphic (NP) and polymorphic (P). After that, they were subdivided according to the cardiorespiratory fitness associated with genotype: high (HNP and HP) and low (LNP and LP). RESULTS: The subjects with polymorphism for the interactions at positions Glu298Asp + intron 4b/a, and Glu298Asp+-786T>C showed the highest values in total cholesterol, as well as dyslipidemia. CONCLUSION: Our findings show that NOS3 gene polymorphisms at positions -786T>C, Glu298Asp, and intron 4b/a exert negative effects on the lipid profile compared with those who do not carry polymorphisms.


Subject(s)
Female , Humans , Male , Middle Aged , Dyslipidemias/genetics , Nitric Oxide Synthase Type III/genetics , Polymorphism, Genetic/genetics , Cardiovascular System/physiopathology , Cholesterol/blood , Dyslipidemias/blood , Dyslipidemias/epidemiology , Epidemiologic Methods , Genotype , Glutamic Acid/genetics , Introns/genetics , Nitrates/blood , Nitrites/blood , Oxygen Consumption/genetics , Promoter Regions, Genetic/genetics , Respiratory System/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL